Cargando…
Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy
OBJECTIVE: To investigate the cost effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes (ACS) in the Platelet Inhibition and Patient Outcomes (PLATO) study who were scheduled for non-invasive management. METHODS: A previously developed cost effectiveness model was...
Autores principales: | Janzon, M, James, S, Cannon, C P, Storey, R F, Mellström, C, Nicolau, J C, Wallentin, L, Henriksson, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316918/ https://www.ncbi.nlm.nih.gov/pubmed/25227704 http://dx.doi.org/10.1136/heartjnl-2014-305864 |
Ejemplares similares
-
Patient and hospital determinants of primary percutaneous coronary intervention in England, 2003–2013
por: Hall, M, et al.
Publicado: (2016) -
Impact of Human Development Index on the profile and outcomes of patients with acute coronary syndrome
por: Roy, Ambuj, et al.
Publicado: (2015) -
Effect of cost sharing on adherence to evidence-based medications in patients with acute coronary syndrome
por: González López-Valcárcel, Beatriz, et al.
Publicado: (2017) -
Determinants of coronary artery disease risk factor management across three world regions
por: Zhao, Min, et al.
Publicado: (2019) -
Challenges in delivering computed tomography coronary angiography as the first-line test for stable chest pain
por: Dreisbach, John G, et al.
Publicado: (2018)